Abbreviation: IMP
A pharmaceutical form of an active substance or placebo being tested or used as a reference in a clinical trial, including products already with a marketing authorization but used or assembled (formulated or packaged) in a way different from the authorized form, or when used for an unauthorized indication, or when used to gain further information about the authorized form.
Original source: Clinical Trials Directive 2001/20/ECxvii
« Back to Glossary Index